The Efficacy and Safety of Endostar Combined With Taxane-based Regimens for HER-2-negative MBC Patients

NCT02865304 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

80

Enrollment

OTHER_GOV

Sponsor class

Conditions

Angiogenesis
Breast Cancer

Interventions

DRUG: endostar

Sponsor

Fujian Cancer Hospital